Taiyen Biotech Co., Ltd. (1737)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
31. 80
+0.05
+0.1575%
NT$
6.39B Market Cap
28.92 P/E Ratio
2.52% Div Yield
94,691 Volume
1.36 Eps
NT$ 31.75
Previous Close Want to track 1737 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiyen Biotech Co., Ltd. (1737) Statistics
Valuation metrics
Market Cap 6.39B
Enterprise value 5.05B
Trailing P/E (ttm) 16.07
Forward P/E -
PEG ratio 1.83
Price/Sales (ttm) 1.94
Price/Book (mrq) 0.92
Enterprise Value/Revenue 1.54
Enterprise Value/EBITDA 7.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 167.38K
Average volume (90 days) 118.54K
Price summary
52-Week low 30.8
52-Week high 33.45
Beta -
50-Day moving average 31.59
200-Day moving average 31.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.3
Trailing annual dividend yield 0.0409%
5-Year annual dividend yield -
Payout ratio 0.65
Dividend Date 16 Sep 2025
Ex-Dividend Date 20 Aug 2025
Last split factor 0:1
Last split Date 16 Dec 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.16%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 16.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.25%
Book value per share (mrq) 34.38
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
